- By insider
CEO and President of Acceleron Pharma Inc (30-Year Financial, Insider Trades) Habib J Dable (insider trades) sold 4,258 shares of XLRN on 01/05/2021 at an average price of $121.13 a share. The total sale was $515,772.
Acceleron Pharma Inc is a biotechnology company which focuses on discovery, development, and commercialization of novel therapies. It aims to discover key natural regulators of cellular growth and repair. Acceleron Pharma Inc has a market cap of $7.37 billion; its shares were traded at around $122.380000 with and P/S ratio of 63.14. GuruFocus has detected 3 severe warning signs with Acceleron Pharma Inc. .
CEO Recent Trades:
-
CEO and President Habib J Dable sold 4,258 shares of XLRN stock on 01/05/2021 at the average price of $121.13. The price of the stock has increased by 1.03% since.
CFO Recent Trades:
-
SVP, CFO and Treasurer Kevin F Mclaughlin sold 42,528 shares of XLRN stock on 12/14/2020 at the average price of $130.14. The price of the stock has decreased by 5.96% since.
-
SVP, CFO and Treasurer Kevin F Mclaughlin sold 7,472 shares of XLRN stock on 12/11/2020 at the average price of $125.02. The price of the stock has decreased by 2.11% since.
For the complete insider trading history of XLRN, click here
.This article first appeared on GuruFocus.